71 related articles for article (PubMed ID: 21062784)
1. A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells.
Watanabe S; Misawa M; Matsuzaki T; Sakurai T; Muramatsu T; Sato M
Glycobiology; 2011 Apr; 21(4):482-92. PubMed ID: 21062784
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of transgenic mice systemically expressing endo-beta-galactosidase C.
Watanabe S; Misawa M; Matsuzaki T; Sakurai T; Muramatsu T; Yokomine TA; Sato M
Glycobiology; 2008 Jan; 18(1):9-19. PubMed ID: 17947256
[TBL] [Abstract][Full Text] [Related]
3. Accelerated proliferation and abnormal differentiation of epidermal keratinocytes in endo-beta-galactosidase C transgenic mice.
Misawa M; Watanabe S; Ihara S; Muramatsu T; Matsuzaki T
Glycobiology; 2008 Jan; 18(1):20-7. PubMed ID: 17951373
[TBL] [Abstract][Full Text] [Related]
4. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells.
Ogawa H; Kobayashi T; Yokoyama I; Nagatani N; Mizuno M; Yoshida J; Kadomatsu K; Muramatsu H; Nakao A; Muramatsu T
Xenotransplantation; 2002 Jul; 9(4):290-6. PubMed ID: 12060465
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
6. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
[TBL] [Abstract][Full Text] [Related]
7. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C.
Liu D; Kobayashi T; Yokoyama I; Ogawa H; Nagasaka T; Muramatsu H; Kadomatsu K; Oikawa T; Shimano Y; Morozumi K; Uchida K; Muramatsu T; Nakao A
Xenotransplantation; 2002 May; 9(3):228-36. PubMed ID: 11983021
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene transfer of endo-beta-galactosidase C removes alphaGal antigen on erythrocytes and endothelial cells of the organs.
Miki Y; Maruyama S; Liu D; Kobayashi T; Sato F; Shimizu H; Kato S; Sato W; Morita Y; Yuzawa Y; Muramatsu T; Matsuo S
Xenotransplantation; 2004 Sep; 11(5):444-51. PubMed ID: 15303981
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta2 regulates growth and differentiation of pulp cells via ALK5/Smad2/3.
Tai TF; Chan CP; Lin CC; Chen LI; Jeng JH; Chang MC
J Endod; 2008 Apr; 34(4):427-32. PubMed ID: 18358889
[TBL] [Abstract][Full Text] [Related]
11. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
[TBL] [Abstract][Full Text] [Related]
13. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
14. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
16. Redirection of B cell responsiveness by transforming growth factor beta receptor.
Roes J; Choi BK; Cazac BB
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
[TBL] [Abstract][Full Text] [Related]
17. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
